@prefix c0x: <http://data.loterre.fr/ark:/67375/C0X> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc11: <http://purl.org/dc/elements/1.1/> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

c0x:-RX4QCFQQ-D
  skos:prefLabel "vaccin à cellules recombinantes"@fr, "recombinant cells vaccine"@en ;
  a skos:Concept ;
  skos:broader c0x:-D2Q1QNZV-7 .

c0x:-WZZNXPM8-T
  skos:prefLabel "inactivated vaccine"@en, "vaccin inerte"@fr ;
  a skos:Concept ;
  skos:broader c0x:-D2Q1QNZV-7 .

c0x:-L7HQXSZF-6
  skos:prefLabel "subunit vaccine"@en, "vaccin sous-unitaire"@fr ;
  a skos:Concept ;
  skos:broader c0x:-D2Q1QNZV-7 .

c0x:-KZ9WGQ59-9
  skos:prefLabel "vaccin"@fr, "vaccine"@en ;
  a skos:Concept ;
  skos:narrower c0x:-D2Q1QNZV-7 .

c0x: a skos:ConceptScheme .
c0x:-QHTWW0GJ-V
  skos:prefLabel "live attenuated vaccine"@en, "vaccin vivant atténué"@fr ;
  a skos:Concept ;
  skos:broader c0x:-D2Q1QNZV-7 .

c0x:-CLRHG06S-0
  skos:prefLabel "viral vaccine vector"@en, "vaccin à vecteur viral"@fr ;
  a skos:Concept ;
  skos:broader c0x:-D2Q1QNZV-7 .

c0x:-W4G74GN8-R
  skos:prefLabel "phase"@en, "phase"@fr ;
  a skos:Concept ;
  skos:related c0x:-D2Q1QNZV-7 .

c0x:-D2Q1QNZV-7
  skos:prefLabel "vaccine candidate"@en, "candidat vaccin"@fr ;
  skos:narrower c0x:-L7HQXSZF-6, c0x:-WZZNXPM8-T, c0x:-CLRHG06S-0, c0x:-RX4QCFQQ-D, c0x:-HDCCRH1K-G, c0x:-QHTWW0GJ-V ;
  skos:definition "Au 22 mai 2020, 95 vaccins étaient en cours de développement, dont plusieurs déjà en cours ou en cours d'essais cliniques, la plupart passant outre la phase I et deux « vaccins expérimentaux » se passant de phase II . Le nombre de vaccins potentiel est passé à près de 200 début juillet 2020. (Wikipédia)"@fr, "A COVID‑19 vaccine is a biotechnology product intended to provide acquired immunity against coronavirus disease 2019 (COVID‑19). As of August 2020, there were 233 vaccine candidates in development, although no candidate has completed clinical trials to prove its safety and efficacy. In August, at least 27 vaccine candidates were in clinical trials, with six beginning Phase III and 21 still in Phase I–II. (Wikipedia)"@en ;
  skos:exactMatch <https://en.wikipedia.org/wiki/COVID-19_vaccine>, <https://fr.wikipedia.org/wiki/Vaccin_contre_la_Covid-19> ;
  dc11:creator "Patricia Fener" ;
  skos:altLabel "candidat-vaccin"@fr, "candidate vaccine"@en ;
  a skos:Concept ;
  skos:broader c0x:-KZ9WGQ59-9 ;
  dc:modified "2020-12-28"^^xsd:date ;
  skos:inScheme c0x: ;
  skos:related c0x:-W4G74GN8-R .

c0x:-HDCCRH1K-G
  skos:prefLabel "vaccin à base d'acide nucléique"@fr, "nucleic acid vaccine"@en ;
  a skos:Concept ;
  skos:broader c0x:-D2Q1QNZV-7 .